Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding.
Kincell Bio has raised $22.0M in total funding. The most recent round was Debt Financing. The last funding was announced in September 2026.
Kincell Bio's investors include JP Morgan, NewSpring, Kineticos Life Sciences, Kineticos Ventures.
Kincell Bio is headquartered in Gainesville, United States.
Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding.
Kincell Bio is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kincell Bio — Funding & Investors." VCBacked, September 17, 2026, https://www.vcbacked.co/company/kincell-bio. Accessed October 6, 2026.
VCBacked. (2026). Kincell Bio — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/kincell-bio
{{cite web |title=Kincell Bio — Funding & Investors |url=https://www.vcbacked.co/company/kincell-bio |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated